- Country: Serbia
- Summary: Procurement of a Registered Drug Outside the List of Drugs for Transplantation Purposes - Maribavir of the University Clinical Center of Vojvodina.
- RST Ref No: 134217651
- Deadline: 05 Feb 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.:Login to see details
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details. Login to see full tender details.
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINProcurement of a Registered Drug Outside the List of Drugs for Transplantation Purposes - Maribavir of the University Clinical Center of Vojvodina. - Serbia Tender
The UNIVERSITY CLINICAL CENTER OF VOJVODINA, a Government sector organization in Serbia, has announced a new tender for Procurement of a Registered Drug Outside the List of Drugs for Transplantation Purposes - Maribavir of the University Clinical Center of Vojvodina.. This tender is published on SerbiaTenders under RST Ref No: 134217651 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-02-05.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
